市場調査レポート
商品コード
1280753

欧州と中東・アフリカの心臓マイクロカテーテル市場の2028年までの予測-適応症、エンドユーザー別の地域別分析

Europe and Middle East & Africa Cardiac Microcatheters Market Forecast to 2028 - Regional Analysis By Indication (General Peripheral Vascular, Coronary), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)

出版日: | 発行: The Insight Partners | ページ情報: 英文 156 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
欧州と中東・アフリカの心臓マイクロカテーテル市場の2028年までの予測-適応症、エンドユーザー別の地域別分析
出版日: 2023年04月26日
発行: The Insight Partners
ページ情報: 英文 156 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州と中東・アフリカの心臓マイクロカテーテル市場は、2022年に9,576万米ドルと評価され、2028年には1億3,605万米ドルに達すると予測されており、2023年から2028年にかけて6.1%のCAGRを記録すると推測されています。心血管疾患の有病率の高さ、慢性完全閉塞(CTO)治療のための経皮的冠動脈インターベンション(PCI)の使用の増加は、欧州と中東・アフリカの心臓マイクロカテーテル市場規模の成長に寄与する主な要因の1つです。欧州と中東・アフリカの心臓マイクロカテーテル市場動向には、新製品の承認、発売、心臓マイクロカテーテル分野における認知度などが含まれます。

マイクロカテーテルは、デバイスを送達するための低侵襲処置に使用される小口径のカテーテルと定義されます。小型であるため、人体内の複雑な血管系を誘導するのに適しています。ガイドワイヤーのサポート、交換、遠位解剖学的構造へのアクセス、病変の横断、治療用塞栓剤の投与、造影剤の注入、および複雑な血管内治療におけるその他の処置の実行に使用されます。また、マイクロカテーテルは経皮的冠動脈形成術(PCI)でもよく使用されています。

慢性完全閉塞症(CTO)治療における経皮的冠動脈インターベンション(PCI)の使用拡大

慢性完全閉塞症(CTO)とは、1本以上の冠動脈が完全に、あるいはほぼ完全に閉塞した状態をいいます。冠動脈内に蓄積したプラークが原因で、閉塞は通常約3カ月続きます。米国国立心肺血液研究所(NHLBI)によると、CTOは血管造影を受けた患者の約3分の1で発見されます。Eurostatによると、2020年には100万件の経管冠動脈形成術と138,000件の心臓バイパス手術が実施されています。CTOの治療において最も困難な経皮的冠動脈形成術(PCI)は、CTOの再疎通を成功に導きます。

慢性完全閉塞症(CTO)の治療は、特に欧州と中東・アフリカでの承認や発売により、過去10年間で大きな進展がありました。しかし、新しいデバイスの発売や、CTOに対抗するための処置における技術的・戦略的な改良は、各地域でまだ改善されていません。マイクロカテーテルは、冠動脈インターベンションツールとして使用されます。このツールは、分岐病変、蛇行した解剖学的構造、骨端位置、冠動脈石灰化、角度のある離床、慢性完全閉塞(CTO)などの複雑な冠動脈介入に治療的アプローチを提供し、欧州と中東・アフリカの循環器医の間で拡大しています。テルモのマイクロカテーテルFineCross MGは、曲がりくねった血管、CTO、分岐部、重度の狭窄や石灰化病変を含む難症例の治療のために、クロス能力とガイドワイヤーサポートを統合しています。

Europa Groupによると、デュアルルーメンマイクロカテーテル(DLMC)は、慢性完全閉塞(CTO)治療のための経皮的冠動脈インターベンション(PCI)において、不可欠なツールとなっています。DLMCは、CTO本体内またはその近傍で分岐した冠動脈枝の保存と管理を可能にします。また、側副血行路の選択、前向きの解離と再エントリー、平行配線の変更、遠位CTOキャップの逆行性ネゴシエーションの使用も可能です。

したがって、慢性完全閉塞(CTO)治療のための経皮的冠動脈インターベンション(PCI)の使用量の増加が、欧州と中東・アフリカの心臓マイクロカテーテル市場を牽引しています。

適応症に基づく洞察

適応症に基づき、欧州と中東・アフリカの心臓マイクロカテーテル市場は、一般的な末梢血管と冠状動脈に二分されます。2022年の市場シェアは、冠動脈セグメントがより大きな割合を占めています。さらに、同セグメントは予測期間中に欧州と中東・アフリカの心臓マイクロカテーテル市場シェアでより高いCAGRを記録すると予想されます。

エンドユーザーベースの洞察

エンドユーザーに基づき、欧州と中東・アフリカの心臓マイクロカテーテル市場は、病院、専門クリニック、外来手術センターに区分されます。2022年の市場シェアは、病院セグメントが最大を占めています。しかし、専門クリニックセグメントは、予測期間中に欧州と中東・アフリカの心臓マイクロカテーテル市場で最も高いCAGRを記録すると予想されます。

欧州と中東・アフリカの心臓マイクロカテーテル市場に関する報告書を作成する際に参照した主な一次情報および二次情報の一部は、国立心肺血液研究所(NHLBI)、健康指標評価研究所、世界保健機関(WHO)です。

目次

第1章 イントロダクション

第2章 欧州と中東・アフリカの心臓マイクロカテーテル市場- 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 心臓マイクロカテーテル市場- 市場情勢

  • PEST分析
  • 専門家の見解

第5章 心臓マイクロカテーテル市場- 主要な市場力学

  • 市場促進要因
    • 心血管疾患の高い有病率
    • 慢性全閉塞(CTO)治療における経皮的冠動脈インターベンション(PCI)の利用拡大
  • 市場抑制要因
    • 心臓マイクロカテーテルの使用に関連する合併症と故障
  • 市場機会
    • ヘルスケア支出の増加、心臓の健康に関する政府主導の取り組み
  • 今後の動向
    • 心臓マイクロカテーテル分野における新製品の承認、上市、認知度の上昇
  • 促進要因と抑制要因の影響分析

第6章 欧州と中東・アフリカの心臓マイクロカテーテル市場分析

  • 欧州と中東・アフリカの心臓マイクロカテーテル市場の収益と予測・分析
    • 心臓マイクロカテーテル市場における主要プレイヤーの市場ポジショニング
      • Medtronic Plc.
      • Boston Scientific Corp

第7章 欧州と中東・アフリカの心臓マイクロカテーテル市場の分析:適応症別

  • 冠動脈
  • 一般末梢血管

第8章 欧州と中東・アフリカの心臓マイクロカテーテル市場分析:エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター

第9章 欧州と中東・アフリカの心臓マイクロカテーテル市場

  • 欧州
    • 欧州の心臓マイクロカテーテル市場:適応症別、2020年~2028年
    • 欧州の心臓マイクロカテーテル市場:エンドユーザー別、2020~2028年
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
  • 中東・アフリカ地域

第10章 欧州と中東・アフリカ:心臓マイクロカテーテル市場

  • 欧州
  • 中東・アフリカの概要

第11章 欧州と中東・アフリカの心臓マイクロカテーテル市場:業界情勢

  • 心臓マイクロカテーテル市場における成長戦略(%)
  • 有機的な展開
  • 無機的な展開

第12章 企業プロファイル

  • Boston Scientific Corp
  • Teleflex Inc
  • Medtronic Plc
  • OrbusNeich Medical Group Holdings Ltd
  • Asahi Intecc USA Inc
  • Merit Medical Systems Inc
  • Nipro Corp
  • Terumo Corp
  • Tokai Medical Products Inc
  • Integer Holdings Corp

第13章 付録

図表

List Of Tables

  • Table 1. Europe Cardiac Microcatheter Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Europe Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. UK Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. UK Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. France Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Italy Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Italy Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Spain Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Spain Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Rest of Europe Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Rest of Europe Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Middle East & Africa Cardiac Microcatheters Market, by Indication- Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Middle East & Africa Cardiac Microcatheters Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Saudi Arabia: Cardiac Microcatheters Market, By Indication -Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Saudi Arabia: Cardiac Microcatheters Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. South Africa: Cardiac Microcatheters Market, By Indication -Revenue and Forecast to 2028 (US$ Million)
  • Table 20. South Africa: Cardiac Microcatheters Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UAE: Cardiac Microcatheters Market, By Indication -Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UAE: Cardiac Microcatheters Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Rest of Middle East & Africa: Cardiac Microcatheters Market, By Indication -Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Rest of Middle East & Africa: Cardiac Microcatheters Market, By End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Organic Developments in the Cardiac Microcatheter Market
  • Table 26. Inorganic Developments in the Cardiac Microcatheter Market
  • Table 27. Glossary of Terms

List Of Figures

  • Figure 1. Cardiac Microcatheter Market Segmentation
  • Figure 2. Cardiac Microcatheter Market Segmentation, by Country
  • Figure 3. Europe and Middle East & Africa Cardiac Microcatheter Market Overview
  • Figure 4. Coronary Held Largest Share of Indication Segment in Cardiac Microcatheters Market
  • Figure 5. Europe and MEA Cardiac Microcatheters Market - Leading Country Markets (US$ Million)
  • Figure 6. EUROPE PEST Analysis
  • Figure 7. MEA PEST Analysis
  • Figure 8. Europe and Middle East & Africa Cardiac Microcatheters Market Impact Analysis of Drivers and Restraints
  • Figure 9. Europe and Middle East & Africa Cardiac Microcatheter Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe and MEA Cardiac Microcatheters Market, by Indication, 2022 & 2028 (%)
  • Figure 11. Coronary: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. General Peripheral Vascular: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Europe and MEA Cardiac Microcatheters Market, by End User, 2022 & 2028 (%)
  • Figure 14. Hospitals: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Specialty Clinics: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Ambulatory Surgical Centers: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Europe Cardiac Microcatheter Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 18. Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Europe Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
  • Figure 20. UK Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Germany Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. France Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Italy Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Spain Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Rest of Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Middle East & Africa Cardiac Microcatheters Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. Middle East & Africa Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Middle East & Africa: Cardiac Microcatheters Market -Revenue and Forecasts to 2028, By Country (%)
  • Figure 29. Saudi Arabia: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. South Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. UAE: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Rest of Middle East & Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 34. Impact of COVID-19 Pandemic on Cardiac Microcatheters Market in the Middle East & Africa
  • Figure 35. Growth Strategies in the Cardiac Microcatheter Market (%)
目次
Product Code: TIPRE00029875

The Europe and Middle East & Africa cardiac microcatheter market was valued at US$ 95.76 million in 2022 and is expected to reach US$ 136.05 million by 2028; it is estimated to register a CAGR of 6.1% from 2023 to 2028. High prevalence of cardiovascular diseases and growing use of percutaneous coronary intervention (PCI) for treating chronic total occlusions (CTO) are among the key factors contributing to the growth of the Europe and Middle East & Africa cardiac microcatheter market size. The Europe and Middle East & Africa cardiac microcatheter market trends include new product approvals, launches, and awareness in the field of cardiac microcatheters.

Microcatheter is defined as a small-diameter catheter that is used in minimally invasive procedures for delivering devices. Its small build makes it ideal for navigating complex vasculature within the human body. It is used for guidewire support, exchanges, access distal anatomy, cross lesions, delivering therapeutic embolic, injecting contrast media, and performing other procedures in complex endovascular procedures. Microcatheters are also commonly used in percutaneous coronary intervention (PCI).

Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)

Chronic total occlusion (CTO) is a complete or near-complete blockage of one or more coronary arteries. The blockage usually lasts approximately three months due to plaque build-up within a coronary artery. As per the National Heart, Lung, and Blood Institute (NHLBI), CTOs are found in approximately one-third of patients undergoing angiography. According to Eurostat, 1.0 million transluminal coronary angioplasty surgeries and 138,000 cardiac bypass surgeries were performed in 2020. Percutaneous coronary intervention (PCI), the most difficult percutaneous procedure for the treatment of CTO, leads to successful recanalization of CTO.

There has been significant progress in the treatment of chronic total occlusions (CTO) over the past decade, owing to the approvals and launches, particularly in Europe and Middle East & Africa. However, the launch of new devices and technical & strategic refinements in the procedures to combat CTOs are still improving in the regions. Microcatheters are used as a coronary interventional tool. This tool provides a therapeutic approach to complex coronary interventions such as bifurcation lesions, tortuous anatomy, ostial location, coronary calcification, angled takeoffs, and chronic total occlusion (CTO), which is growing among cardiologists across Europe and Middle East & Africa. Terumo's FineCross MG microcatheter integrates cross ability and guidewire support for the treatment of challenging cases involving tortuous vessels, CTO, bifurcations, and severely stenosed and calcified lesions.

According to Europa Group, dual-lumen microcatheters (DLMC) have become indispensable tools in the context of percutaneous coronary intervention (PCI) for the treatment of chronic total occlusion (CTO). DLMC allows the preservation and management of bifurcated coronary branches within or near the CTO body. It also enables the usage of collateral selection, antegrade dissection and re-entry, modified parallel wiring, and retrograde negotiation of the distal CTO cap.

Therefore, the growing usage of percutaneous coronary interventions (PCI) for treating chronic total occlusion (CTO) is driving the Europe and Middle East & Africa cardiac microcatheter market.

Indication-Based Insights

Based on indication, the Europe and Middle East & Africa cardiac microcatheter market is bifurcated into general peripheral vascular and coronary. The coronary segment accounted for a larger market share in 2022. Moreover, the same segment is expected to register a higher CAGR of the Europe and Middle East & Africa cardiac microcatheter market share during the forecast period.

End User-Based Insights

Based on end user, the Europe and Middle East & Africa cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment accounted for the largest market share in 2022. However, the specialty clinics segment is expected to register the highest CAGR of the Europe and Middle East & Africa cardiac microcatheter market during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the Europe and Middle East & Africa cardiac microcatheter market are National Heart, Lung, and Blood Institute (NHLBI); Institute for Health Metrics and Evaluation; and World Health Organization (WHO).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe and MEA cardiac microcatheters market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe and MEA cardiac microcatheters market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook in regional market coupled with the factors driving the market, as well as those hindering it.
  • Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe and Middle East & Africa Cardiac Microcatheter Market - by Indication
    • 1.3.2 Europe and Middle East & Africa Cardiac Microcatheter Market - by End User
    • 1.3.3 Europe and Middle East & Africa Cardiac Microcatheter Market - by Geography

2. Europe and Middle East & Africa Cardiac Microcatheter Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Cardiac Microcatheter Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Experts' Opinion

5. Cardiac Microcatheter Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Prevalence of Cardiovascular Diseases
    • 5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
  • 5.2 Market Restraints
    • 5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheters
  • 5.3 Market Opportunity
    • 5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
  • 5.4 Future Trends
    • 5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheters
  • 5.1 Impact Analysis of Drivers and Restraints

6. Europe and Middle East & Africa Cardiac Microcatheter Market Analysis

  • 6.1 Europe and Middle East & Africa Cardiac Microcatheter Market Revenue Forecast and Analysis
    • 6.1.1 Market Positioning of Key Players in Cardiac Microcatheter Market
      • 6.1.1.1 Medtronic Plc.
      • 6.1.1.2 Boston Scientific Corp

7. Europe and Middle East & Africa Cardiac Microcatheter Market Analysis - by Indication

  • 7.1 Overview
  • 7.2 Coronary
    • 7.2.1 Overview
    • 7.2.2 Coronary: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.3 General Peripheral Vascular
    • 7.3.1 Overview
    • 7.3.2 General Peripheral Vascular: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe and Middle East & Africa Cardiac Microcatheter Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Hospitals
    • 8.2.1 Overview
    • 8.2.2 Hospitals: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.3 Specialty Clinics
    • 8.3.1 Overview
    • 8.3.2 Specialty Clinics: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Ambulatory Surgical Centers
    • 8.4.1 Overview
    • 8.4.2 Ambulatory Surgical Centers: Europe and MEA Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe and Middle East & Africa Cardiac Microcatheter Market

  • 9.1 Europe
    • 9.1.1 Overview
    • 9.1.2 Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
    • 9.1.4 Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.1 UK
        • 9.1.4.1.1 Overview
        • 9.1.4.1.2 UK Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.1.3 UK Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.4.1.4 UK Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.2 Germany
        • 9.1.4.2.1 Overview
        • 9.1.4.2.2 Germany Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.2.3 Germany Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.4.2.4 Germany Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.3 France
        • 9.1.4.3.1 Overview
        • 9.1.4.3.2 France Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.3.3 France Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.4.3.4 France Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.4 Italy
        • 9.1.4.4.1 Overview
        • 9.1.4.4.2 Italy Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.4.3 Italy Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.4.4.4 Italy Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.5 Spain
        • 9.1.4.5.1 Overview
        • 9.1.4.5.2 Spain Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.5.3 Spain Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
        • 9.1.4.5.4 Spain Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
      • 9.1.4.6 Rest of Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.6.1 Overview
        • 9.1.4.6.2 Rest of Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.6.3 Rest of Europe Cardiac Microcatheter Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.4.6.4 Rest of Europe Cardiac Microcatheter Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • 9.2 Middle East & Africa
    • 9.2.1 Overview
    • 9.2.2 Middle East & Africa Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Middle East & Africa: Cardiac Microcatheters Market- Revenue and Forecasts to 2028, By Indication (US$ Million)
    • 9.2.4 Middle East & Africa: Cardiac Microcatheters Market- Revenue and Forecasts to 2028, By End User (US$ Million)
    • 9.2.5 Middle East & Africa: Cardiac Microcatheters Market- Revenue and Forecasts to 2028, By Country (%)
      • 9.2.5.1 Saudi Arabia: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 Overview
        • 9.2.5.1.2 Saudi Arabia: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.3 Saudi Arabia: Cardiac Microcatheters Market -Revenue and Forecasts to 2028, By Indication (US$ Million)
        • 9.2.5.1.4 Saudi Arabia: Cardiac Microcatheters Market - Revenue and Forecasts to 2028, By End User (US$ Million)
      • 9.2.5.2 South Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 Overview
        • 9.2.5.2.2 South Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.3 South Africa: Cardiac Microcatheters Market -Revenue and Forecasts to 2028, By Indication (US$ Million)
        • 9.2.5.2.4 South Africa: Cardiac Microcatheters Market - Revenue and Forecasts to 2028, By End User (US$ Million)
      • 9.2.5.3 UAE: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 Overview
        • 9.2.5.3.2 UAE: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.3 UAE: Cardiac Microcatheters Market -Revenue and Forecasts to 2028, By Indication (US$ Million)
        • 9.2.5.3.4 UAE: Cardiac Microcatheters Market - Revenue and Forecasts to 2028, By End User (US$ Million)
      • 9.2.5.4 Rest of Middle East & Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Overview
        • 9.2.5.4.2 Rest of Middle East & Africa: Cardiac Microcatheters Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.3 Rest of Middle East & Africa: Cardiac Microcatheters Market -Revenue and Forecasts to 2028, By Indication (US$ Million)
        • 9.2.5.4.4 Rest of Middle East & Africa: Cardiac Microcatheters Market - Revenue and Forecasts to 2028, By End User (US$ Million)

10. Europe and Middle East & Africa Cardiac Microcatheter Market: Impact Assessment of COVID-19 Pandemic

  • 10.1 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.2 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11. Europe and Middle East & Africa Cardiac Microcatheter Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Cardiac Microcatheter Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boston Scientific Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Teleflex Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Medtronic Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 OrbusNeich Medical Group Holdings Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Asahi Intecc USA Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Merit Medical Systems Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Nipro Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Terumo Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Tokai Medical Products Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Integer Holdings Corp
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms